Clinical Research
Neonatology
Pulmonology
Trainee
Anup Katheria, MD
Physician
Sharp Mary Birch Hospital for Women & Newborns
San Diego, California, United States
Charles Christoph Roehr, MD, PhD (he/him/his)
Professor of Neonatal and Perinatal Medicine
University of Bristol
Bristol, England, United Kingdom
There is a large body of evidence that has now demonstrated that non-invasive surfactant administration has benefits for term and preterm infants. These benefits include reductions in morbidities such as bronchopulmonary dysplasia. Less invasive methods may have benefits not seen with traditional administration of surfactant such as rescue vs prophylactic administration in the delivery room. Conversely, other methods may be only used on larger and less preterm infants due to size and logistical constraints. This session will review the evidence for such approaches from large cohort studies to randomized controlled trials, as well as experience from centers having developed these techniques. We have assembled international experts on surfactant administration including the director for Cochrane Neonatal, expert trialists for surfactant administration, and guideline experts from the European consensus statements on the management of respiratory distress syndrome.
Speaker: Anup Katheria, MD – Sharp Mary Birch Hospital for Women & Newborns
Speaker: Christoph Härtel, MD (he/him/his) – University Hospital Würzburg, Pediatrics
Speaker: Charles Christoph Christoph Roehr, MD, PhD (he/him/his) – University of Bristol
Speaker: Calum T. Roberts, PhD (he/him/his) – Monash University
Speaker: Kari Roberts, MD – University of Minnesota
Speaker: Roger Soll, MD – Robert Larner, M.D., College of Medicine at the University of Vermont